These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 25987427
1. Inter-observer agreement for the evaluation of bone involvement on Whole Body Low Dose Computed Tomography (WBLDCT) in Multiple Myeloma (MM). Zacchino M, Bonaffini PA, Corso A, Minetti V, Nasatti A, Tinelli C, Dore R, Calliada F, Sironi S. Eur Radiol; 2015 Nov; 25(11):3382-9. PubMed ID: 25987427 [Abstract] [Full Text] [Related]
2. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Horger M, Claussen CD, Bross-Bach U, Vonthein R, Trabold T, Heuschmid M, Pfannenberg C. Eur J Radiol; 2005 May; 54(2):289-97. PubMed ID: 15837412 [Abstract] [Full Text] [Related]
4. Whole-body ultra-low dose CT using spectral shaping for detection of osteolytic lesion in multiple myeloma. Suntharalingam S, Mikat C, Wetter A, Guberina N, Salem A, Heil P, Forsting M, Nassenstein K. Eur Radiol; 2018 Jun; 28(6):2273-2280. PubMed ID: 29322333 [Abstract] [Full Text] [Related]
5. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI). Gleeson TG, Moriarty J, Shortt CP, Gleeson JP, Fitzpatrick P, Byrne B, McHugh J, O'Connell M, O'Gorman P, Eustace SJ. Skeletal Radiol; 2009 Mar; 38(3):225-36. PubMed ID: 19009290 [Abstract] [Full Text] [Related]
9. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma. Lai AYT, Riddell A, Barwick T, Boyd K, Rockall A, Kaiser M, Koh DM, Saffar H, Yusuf S, Messiou C. Eur Radiol; 2020 Jan; 30(1):320-327. PubMed ID: 31267214 [Abstract] [Full Text] [Related]
10. Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography. Schabel C, Horger M, Kum S, Weisel K, Fritz J, Ioanoviciu SD, Bier G. Eur J Radiol; 2016 Dec; 85(12):2195-2199. PubMed ID: 27842666 [Abstract] [Full Text] [Related]
11. Diagnostic value of whole-body ultra-low dose computed tomography in comparison with spinal magnetic resonance imaging in the assessment of disease in multiple myeloma. Ippolito D, Talei Franzesi C, Spiga S, Besostri V, Pezzati S, Rossini F, Sironi S. Br J Haematol; 2017 May; 177(3):395-403. PubMed ID: 28233900 [Abstract] [Full Text] [Related]
13. Role of whole-body 64-slice multidetector computed tomography in treatment planning for multiple myeloma. Razek AA, Ezzat A, Azmy E, Tharwat N. Radiol Med; 2013 Aug; 118(5):799-805. PubMed ID: 22986700 [Abstract] [Full Text] [Related]
15. Inter-observer agreement of baseline whole body MRI in multiple myeloma. Croft J, Riddell A, Koh DM, Downey K, Blackledge M, Usher M, Boyd K, Kaiser M, Messiou C. Cancer Imaging; 2020 Jul 14; 20(1):48. PubMed ID: 32665028 [Abstract] [Full Text] [Related]
19. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)? Spira D, Weisel K, Brodoefel H, Schulze M, Kaufmann S, Horger M. Acad Radiol; 2012 Jan 14; 19(1):89-94. PubMed ID: 22142681 [Abstract] [Full Text] [Related]